Johnson & Johnson to Acquire Abiomed

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SBUX
2. SPCX
3. LEVI
4. NVDA
5. AAPL
6. GOOGL
7. ORCL
8. CMG
9. SPY
10. ALHC

Go back to Johnson & Johnson to Acquire Abiomed

Johnson & Johnson's (JNJ) $16.6bn Deal for Abiomed (ABMD) Deal a Positive - Stifel

November 1, 2022 10:00 AM EDT

Johnson & Johnson (NYSE: JNJ) announced Tuesday that it has agreed a $16.6 billion deal to acquire heart pump maker Abiomed (NASDAQ: ABMD).

The company will pay $380 per share in cash for Abiomed, representing an over 50% premium to Abiomed's last closing price. The deal is set to be completed before the end of the first quarter of 2023. In addition, Abiomed shareholders will also receive up to $35 per share in cash if certain commercial and clinical milestones are achieved.

Johnson &... More